New England Journal of Medicine, Volume 383, Issue 5, July 2020.
Wed Jul 29, 2020 12:27
New England Journal of Medicine, Ahead of Print.
Wed Jul 29, 2020 12:04
New England Journal of Medicine, Ahead of Print.
Wed Jul 29, 2020 12:04
New England Journal of Medicine, Ahead of Print.
Wed Jul 29, 2020 12:04
New England Journal of Medicine, Ahead of Print.
Wed Jul 29, 2020 12:04
New England Journal of Medicine, Volume 383, Issue 5, July 2020.
Wed Jul 29, 2020 12:00
New England Journal of Medicine, Volume 383, Issue 5, Page 489-490, July 2020.
Wed Jul 29, 2020 12:00
New England Journal of Medicine, Volume 383, Issue 5, Page 460-473, July 2020.
Wed Jul 29, 2020 12:00
New England Journal of Medicine, Volume 383, Issue 5, Page 415-425, July 2020.
Wed Jul 29, 2020 12:00
New England Journal of Medicine, Volume 383, Issue 5, Page 408-410, July 2020.
Wed Jul 29, 2020 12:00
New England Journal of Medicine, Volume 383, Issue 5, Page 411-413, July 2020.
Wed Jul 29, 2020 12:00
New England Journal of Medicine, Volume 383, Issue 5, Page 500-502, July 2020.
Wed Jul 29, 2020 12:00
New England Journal of Medicine, Volume 383, Issue 5, Page 498-500, July 2020.
Wed Jul 29, 2020 12:00
New England Journal of Medicine, Volume 383, Issue 5, July 2020.
Wed Jul 29, 2020 12:00
New England Journal of Medicine, Volume 383, Issue 5, Page 440-451, July 2020.
Wed Jul 29, 2020 12:00
New England Journal of Medicine, Volume 383, Issue 5, Page 405-408, July 2020.
Wed Jul 29, 2020 12:00
New England Journal of Medicine, Volume 383, Issue 5, Page 487-488, July 2020.
Wed Jul 29, 2020 12:00
New England Journal of Medicine, Volume 383, Issue 5, July 2020.
Wed Jul 29, 2020 12:00
New England Journal of Medicine, Volume 383, Issue 5, Page 474-474, July 2020.
Wed Jul 29, 2020 12:00
New England Journal of Medicine, Volume 383, Issue 5, Page 426-439, July 2020.
Wed Jul 29, 2020 12:00
New England Journal of Medicine, Volume 383, Issue 5, Page 491-493, July 2020.
Wed Jul 29, 2020 12:00
New England Journal of Medicine, Volume 383, Issue 5, Page 452-459, July 2020.
Wed Jul 29, 2020 12:00
New England Journal of Medicine, Volume 383, Issue 5, Page 486-487, July 2020.
Wed Jul 29, 2020 12:00
Mark above section as read
Respiratory syncytial virus (RSV) is the most common cause of lower respiratory tract disease and hospitalizations for respiratory illness among infants and young children, resulting in largely predictable annual epidemics worldwide. RSV is a leading cause of infant deaths, primarily in low-income…
The prevalence of uterine fibroids, the most common type of tumor among women of reproductive age, increases with age. Approximately half of women with fibroids have bothersome symptoms, including heavy menstrual bleeding, abdominal pain, and pressure, that negatively affect quality of life.…
Respiratory syncytial virus (RSV) is the dominant cause of hospitalizations in infants with lower respiratory tract infections. In 2015, an estimated 3.2 million hospitalizations for RSV-associated lower respiratory tract infection occurred in children younger than 5 years of age worldwide; 118,000…
Yellow fever is an acute viral hemorrhagic disease. This disease is caused by the yellow fever virus, which is currently enzootic in the forests of South America and sub-Saharan Africa. Spillover transmission of yellow fever virus from the enzootic cycles into humans is now occurring at increasing…
Mark above section as read
Figure 1.
Mark above section as read
Monocytes, macrophages, and myeloid dendritic cells are central to the host response to cancer, and generally not in a good way. Tumor-associated macrophages, often the most abundant cells in tumor microenvironments, are recruited and "corrupted" by malignant cells to aid the growth and spread of…
Raw data, including digital sequence information derived from human genomes, have in recent years emerged as a top global commodity. This shift is so new that experts are still evaluating what such information is worth in a global market. In 2018, the direct-to-consumer genetic-testing company…
Mark above section as read
The disproportionate effects of the Covid-19 pandemic on African Americans, Latinx Americans, and Native Americans is not unforeseen. Inequities in health, health care access, and quality of care are ingrained in the U.S. health care system. These inequities are not a sign of a broken system: in…
Thu Jul 30, 2020 03:00
It has been said that every system is perfectly designed to get the results it gets. The strengths, weaknesses, flaws, and complexity of every health care system stem in large part from health policies. The U.S. health care system did not arise randomly but through a series of deliberate policy…
Thu Jul 30, 2020 03:00
An elderly woman with hypertension, diabetes, and obesity has been living independently. Over the past week, she has developed a new cough and shortness of breath on exertion. She wonders whether to call her doctor’s office for advice but decides to wait and try home remedies recommended by…
Thu Jul 30, 2020 03:00
For the past 6 months, policymakers and the U.S. public have weighed economic against public health considerations in debating what limits to set on individual and collective behaviors in attempting to control the Covid-19 pandemic. As fall approaches, attention has turned to a third pillar of a…
Wed Jul 29, 2020 03:00
Mark above section as read
Chronic lymphocytic leukemia (CLL) cells proliferate in secondary lymphoid organs (lymph nodes and spleen), where B-cell receptor signaling promotes the expansion of the monoclonal B lymphocytes. B-cell receptor signaling is the target of kinase inhibitors, which have transformed CLL therapy during…
To the Editor: Targeted agents replace chemoimmunotherapy for most patients with chronic lymphocytic leukemia (CLL). In randomized trials of ibrutinib or venetoclax, the risk of progression or death in patients with CLL was up to 75% lower than that with chemoimmunotherapy. Venetoclax-based,…
Mark above section as read
A 77-year-old man presented to the emergency department with nausea, vomiting, and diarrhea. He had no known medical or surgical history and reported no shortness of breath or cough. Physical examination was notable for decreased breath sounds in the lower third of the right side of the chest, and…
Thu Jul 30, 2020 03:00
Mark above section as read
Presentation of Case. Dr. Jonathan E. Eisen: A 47-year-old woman presented to this hospital early during the pandemic of coronavirus disease 2019 (Covid-19), the disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), because of cough and shortness of breath. The patient had…
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (Covid-19), is responsible for the 2020 global pandemic. Developing a vaccine that is safe, effective, and rapidly deployable is an urgent global health priority. The majority of vaccine…
Mark above section as read
Mark above section as read
Hysterectomy remains the one-size-fits-all treatment for uterine fibroids. Despite the fact that more than 8000 women have participated in randomized clinical trials that compared uterine-artery embolization with surgery, only a few hundred of these women underwent myomectomy, the uterine-sparing…
Mark above section as read
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου